“FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES”. CAHIERS MAGELLANES-NS, vol. 6, no. 2, Nov. 2024, pp. 7092-01, http://cahiersmagellanes.com/index.php/CMN/article/view/1040.